Register entry
UPJOHN US 2 LLC
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 18
- Countries
- 0
Exclusivity
Patents and exclusivities
18| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 10022447 | LYRICA CRpregabalin | use | Nov 2026 |
| 8945620 | LYRICA CRpregabalin | product | Nov 2026 |
| 9144559 | LYRICA CRpregabalin | product | Nov 2026 |
| 10022447*PED | LYRICA CRpregabalin | use | May 2027 |
| 8945620*PED | LYRICA CRpregabalin | use | May 2027 |
| 9144559*PED | LYRICA CRpregabalin | use | May 2027 |
Enquiry
Common questions
- Is UPJOHN US 2 LLC FDA approved?
- UPJOHN US 2 LLC holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.